StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca core gross margin (% of product sales) (%)

Form 6-K / 20-F Core Financial Measures

Latest, Q2 2026
84.0%
Period ended Jun 30, 2026
Change on a year earlier
+2.0 pts
82.0% in Q2 2025
History
16 quarters
Since Q4 2020
Sources
16
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCore gross margin (% of product sales) (%)Year on yearSource
Q2 2026Jun 30, 202684.0%+2.0 ptsForm 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 202683.0%-1.0 ptsForm 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 202580.0%–Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 202582.0%–Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 202582.0%–Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 202584.0%–Form 6-K FY2025Q1 Earnings Release ↗
Q1 2023Mar 31, 202383.3%+4.0 ptsForm 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 202277.2%+2.9 ptsForm 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 202280.8%+6.3 ptsForm 6-K FY2022Q3 Earnings Release ↗
Q2 2022Jun 30, 202282.9%+9.9 ptsForm 6-K FY2022Q2 Earnings Release ↗
Q1 2022Mar 31, 202279.3%+4.7 ptsForm 6-K FY2022Q1 Earnings Release ↗
Q4 2021Dec 31, 202174.3%-4.3 ptsForm 6-K FY2021Q4 Earnings Release ↗
Q3 2021Sep 30, 202174.5%–Form 6-K FY2021Q3 Earnings Release ↗
Q2 2021Jun 30, 202173.0%–Form 6-K FY2021Q2 Earnings Release ↗
Q1 2021Mar 31, 202174.6%–Form 6-K FY2021Q1 Earnings Release ↗
Q4 2020Dec 31, 202078.6%–Form 6-K FY2020Q4 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Core gross margin (% of product sales) (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/core_gross_margin_pct

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.